DXR:

*Data is delayed | USD

After Hours: Last |

()

9.41

()

52 week range

Open-
Day High-
Day Low-
Prev Close-
52 Week High-
52 Week High Date-
52 Week Low-
52 Week Low Date-

Key Stats

Market Cap-
Shares Out-
10 Day Average Volume-
Dividend-
Dividend Yield-
Beta-
YTD % Change-

KEY STATS

Open-
Day High-
Day Low-
Prev Close-
52 Week High-
52 Week High Date-
52 Week Low-
52 Week Low Date-
Market Cap-
Shares Out-
10 Day Average Volume-
Dividend-
Dividend Yield-
Beta-
YTD % Change-

RATIOS/PROFITABILITY

EPS (TTM)-
P/E (TTM)-
Fwd P/E (NTM)-
EBITDA (TTM)-
ROE (TTM)-
Revenue (TTM)-
Gross Margin (TTM)-
Net Margin (TTM)-
Debt To Equity (MRQ)-

EVENTS

Earnings Date-
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On undefined

Content From Our Affiliates

There is no recent news for this security.

Profile

Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at hospital centers across the United...

Michael Feldschuh

Chairman of the Board, President, Chief Executive Officer

Robert Michel

Chief Financial Officer, Chief Compliance Officer

Address

SUITE 7120, 350 FIFTH AVENUE

New York, NY

10118

United States

https://www.daxor.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
SVVC Firsthand Technology Value Fund Inc	0.1628	-0.0122	-6.9734%
SSSS SuRo Capital Corp	4.46	+0.15	+3.48%
SSIC Silver Spike Investment Corp	11.22	-0.13	-1.15%
LRFC Logan Ridge Finance Corp	22.55	+0.07	+0.31%
ICMB Investcorp Credit Management BDC Inc	3.25	+0.01	+0.31%